chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Numbness; tingling; dizziness; vertigo; diarrhea; heartburn; head pain; ear pain; tinnitus; joint pain; flushing; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 47 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 14Apr2021 13:30 (Lot number: EW0153) at the age of 47 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: TAMOXIFEN; ZYRTEC [CETIRIZINE HYDROCHLORIDE]. Vaccination history included: Bnt162b2 (dose 1, lot number: ER2613, administration time: 01:30PM , vaccine location: Left arm), administration date: 24Mar2021, when the patient was 47 years old, for COVID-19 immunization. Patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19; and since the vaccination, has been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine.  The following information was reported: HYPOAESTHESIA (disability) with onset 26Apr2021 10:00, outcome "not recovered", described as "Numbness"; PARAESTHESIA (disability) with onset 26Apr2021 10:00, outcome "not recovered", described as "tingling"; DIZZINESS (disability) with onset 26Apr2021 10:00, outcome "not recovered", described as "dizziness"; VERTIGO (disability) with onset 26Apr2021 10:00, outcome "not recovered", described as "vertigo"; DIARRHOEA (disability) with onset 26Apr2021 10:00, outcome "not recovered", described as "diarrhea"; DYSPEPSIA (disability) with onset 26Apr2021 10:00, outcome "not recovered", described as "heartburn"; HEADACHE (disability) with onset 26Apr2021 10:00, outcome "not recovered", described as "head pain"; EAR PAIN (disability) with onset 26Apr2021 10:00, outcome "not recovered", described as "ear pain"; TINNITUS (disability) with onset 26Apr2021 10:00, outcome "not recovered", described as "tinnitus"; ARTHRALGIA (disability) with onset 26Apr2021 10:00, outcome "not recovered", described as "joint pain"; FLUSHING (disability) with onset 26Apr2021 10:00, outcome "not recovered", described as "flushing". The events "numbness", "tingling", "dizziness", "vertigo", "diarrhea", "heartburn", "head pain", "ear pain", "tinnitus", "joint pain" and "flushing" were evaluated at the physician office visit. The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (21Jan2022) negative. Therapeutic measures were taken as a result of hypoaesthesia, paraesthesia, dizziness, vertigo, diarrhoea, dyspepsia, headache, ear pain, tinnitus, arthralgia, flushing on an unspecified date in May2021.  No follow-up attempts are possible. No further information is expected.
pt recv vax 12NOV98 & 22DEC98 pt was seen for chickenpox;26DEC98 pt was hosp & dx w/staphylococcus infect secondary to impetigo;28DEC98 pt discharged;Annual follow-up dated 11/27/00 provided no additional data.
My COVID-19 infection symptoms started on 02/02/2023 in the afternoon. I had a sore throat. The next morning I had chills, fever, nasal congestions, body aches, sore throat, joints on my right hand was burning and painful. I did a home COVID-19 test which was positive. My oxygen level was 87. I went to an urgent care right away. At the urgent care they prescribe PAXLOVID and advised me to take ibuprofen. I also took MUCINEX once a day. I tested positive for 1 whole week. The knuckles on my right hand sometimes burns and painful as of now but all the other symptoms are gone.
On March 23 I first noticed reduced hearing in my right ear. Went to doc on March 25. Doc said allergies and had me start Flonase. No change in hearing. Back to doc on March 31. She performed a warm water wash in my ear and said infection and prescribed amoxicillin. April 3 woke up and hearing was worse.
The morning after my 2nd moderna covid shot. I heard deep whistling in my ears. Ever since I?ve had a buzzing in my ears that is the worst when I first wake up. It is tinnitus and I?ve had it for about a week. I?m going crazy and I would have not took the shot if I knew this was going to happen.
Localized redness, little bumpy, redness to touch presentation day after vaccine was administered. Area is swollen and this has gone down a little bit after 2 days. Area is also a little itchy. Area 2x4 Recommended treatment-cold compress to area, Antihistamine such as BENADRYL and topical Hydrocortisone if needed for itching. Recommended to follow up with MD early next if no improvement.
Hospitalized 12/24/21-01/07/2022, SOB, fatigue, HA, cough, hypoxia, PNA, GI bleed, anemia,
having heart palpitations; weird rashes; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the parent. This consumer reported different events for different patients. This is 2 of 3 reports.   A 44 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. The patient took concomitant medications. Vaccination history included: Bnt162b2 (Dose: 1), for COVID-19 immunization. The following information was reported: PALPITATIONS (non-serious), outcome "unknown", described as "having heart palpitations"; RASH (non-serious), outcome "unknown", described as "weird rashes". Clinical information: Within the caller's original report the parent (mother) mentioned that her daughter had all kinds of issues after she had the 2nd dose, but that is her daughter's story to tell not hers. Her daughter has not been the same since she had the vaccine, she is 44 years old and she is now on beta blockers and is having heart palpitations and weird rashes and obviously her daughter is blaming everything on the vaccine.   Follow-up attempts are completed. No further information expected.
Date of vax & 2 days thereafter soreness, redness around inject site; 3 days p/inject developed limited ROM in shoulder joint; Now persistent pain & limited ROM lt shoulder since; continues @ present time 12NOV91;
13 month old child received MMR and Varivax vaccines on 6/10/05 at approximately 4:00 PM.  8 hours later (around midnight), the mother noted that the child was in respiratory distress as described by shallow rapid breathing, wheezing, possible stridor.  The child was seen at a local ER and noted to be hypoxic intially with Sao2 = 91%, CXR clear, responded to oxygen/mist and IM steroids and sent home with diagnosis of croup.  Developed rhinorrea the next morning, possibly suggestive of viral infection.  However, the child does have a history of atopy/allergy and has had allergic reactions to insect bites in past consisting of swelling/erythema but not respiratory distress.
patient was walked down the hallway and fell to the floor  shaking,  passed out  for  3 to 4 seconds.   Put my hand under his head and held him and talked to him to bring him back to consciousness. Once he woke I walked him to the room laid him on the bed and propped his feet. Gave him a cool drink of water and made him sit for 15 mins.
12 1245 `/15/17 pt complained of hunger; dizziness. Per pt spent the night at friends house; had not eaten/ Since, pt displayed muscle convulsions, pale skin, weak pulse; clammy skin, local fire department responded and pt was taken care of.
Information has been received from a public health center nurse concerning a school-aged pt (age and gender not reported) who, after age 1 had been vaccinated with 0.5mL first and second doses of MMRII (Lot # not reported). Subsequently the pt developed rubella, which was confirmed by IgM. The pt had a reddish rash, swollen lymph nodes, but no history of fever. Unspecified medical attention was sought. The pt's outcome was not reported. It was also reported that the pt's sibling had been vaccinated with MMRII and developed rubella (WAES # 0403USA01259).  Additional information has been requested.
On 4/4/21, the patient listed below was given her first dose of the Pfizer vaccine. The patient neglected to mention to anyone until after vaccination that she had already received the Moderna vaccine at a local fire department 3 weeks ago. This Moderna vaccine was not logged in to the system due to the location of the vaccination in the community.
Extreme rash on multiple parts of body including on my lower abdomen and belly button (red inflamed spots that were itchy for 2 weeks) and ears. The backs of my ears were red, hot to the touch and turned ?leathery?, dry itchy skin for about a week and a half.  I tried anti-itch creams, aloe, witch hazel and lotions to treat. Nothing worked and it eventually went away on its own. I have never experienced this prior to the vaccine.
Information has been received from a nurse concerning a 65 year old white male patient with no known drug allergies or illnesses at the time of vaccination who on 17-OCT-2007 was vaccinated subcutaneously in the left deltoid with the first dose of ZOSTAVAX (Oka/Merck) (Lot # 657766/0620U). Concomitant vaccination included sterile diluent (Lot #3035U). The reporter indicated that the patient complained of rash on legs beginning on 27-Oct-2007. The rash was mildly itchy, non-tender, but the patient knew they were there. There was no rash at the site of injection. There were four scattered light erythematous papules on his leg. There was no discharge or vesicles noted. No laboratory diagnostic tests were performed. The patient outcome is recovered. It was noted that on 18-SEP-2007, the patient was vaccinated with the first dose of Pneumovax (Lot # 657526/0555U). No reaction was attributed to any of the vaccines. Follow-up information has been received from a registered nurse indicating that the patient only received one dose of Pneumovax (MSD) (lot # 657526/0555U) on 18-SEP-2007 and no previous vaccinations were given of this vaccine as previously reported. The adverse events resolved (no dates provided). The treating physician did not consider the events to be related to any of the therapies (zoster vaccine live (Oka/Merck), sterile diluent or Pneumovax). No further information is available. This is in follow-up to report previously submitted on 12/21/2007. This is an amended report. One dose of pneumococcal 14v polysaccharide vaccine now reads pneumococcal 23v polysaccharide vaccine (MSD) (lot # 657526/0555U) instead of pneumococcal 14v polysaccharide vaccine (MSD). No further information is available.
No adverse event; Pediatric Moderna administered to adult patient instead of Moderna bivalent; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Pediatric Moderna administered to adult patient instead of Moderna bivalent) and NO ADVERSE EVENT (No adverse event) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AR6965B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 30-Sep-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 30-Sep-2022, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Pediatric Moderna administered to adult patient instead of Moderna bivalent). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Pediatric Moderna administered to adult patient instead of Moderna bivalent) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Pediatric Moderna administered to adult patient instead of Moderna bivalent).    Concomitant medication information was not provided by the reporter.  The patient received 1st booster dose, after having the primary series.   The patient has not reported any adverse reactions to this dose at this time.  Treatment information was not provided by the reporter.
cold; chills; shaking; a fever 100.1; She dozed and went to sleep; This is a spontaneous report from a contactable consumer or other non hcp (Patient). A 76-years-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Batch number/Lot Number: ER8737), via an unspecified route of administration in Arm on 05May2021 (Age at vaccination 76-years-old), as DOSE 2, SINGLE for covid-19 immunization. Medical history included bad back which have been for 15 years or longer, high blood pressure which had for 20-something years, gastro stomach problems which had for 15 years, probably 10 to 15 years, blood clot, blood thinner, covid-19 from unspecified date in Jan2021 to an unknown date. Concomitant medications included cetirizine taken for hypersensitivity, apixaban (ELIQUIS) taken for anticoagulant therapy, lisinopril taken for blood pressure measurement, amlodipine (AMLODIPINE) taken for blood pressure measurement, famotidine, ergocalciferol (VIT D), ascorbic acid (VITAMIN-C). Patient did not receive any other vaccinations within four weeks prior to the Covid1-19 vaccine. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Batch number/Lot Number: ER8727), via an unspecified route of administration in Arm left on 16Apr2021 as DOSE 1, SINGLE for covid-19 immunization and experienced fever and chills. Patient reported that she took her first vaccine and then she had chills so bad she could not stop shaking. Patient had a fever 100 and cold which was last night. She does not feel bad, she does not feel sick or anything. She guesses it is because of the blood thinners she is taking because she had COVID but had a clot in her lung. Her doctor said the clot is gone but the doctor wanted her to finish taking the blood thinner. Patient added there was nothing else, just she was so cold she could not take her blood pressure. She dozed and went to sleep. She stated that thank God this morning she was not cold. Patient stated that she did some lab work but that was last week. The only thing the doctor did was give her a chest, nuclear. Patient confirms as chest, nuclear. She thinks that is how it is spelled, like a nuclear bomb. The doctor said the clot was gone. The doctor did not see it, that is why they did a nuclear test and they injected nuclear fluid into her arm so it could go to her lungs to let them know if anything was still there. She developed the blood clot when she got COVID. The outcome of all the events was unknown  No follow-up attempts are needed. No further information is expected.
This spontaneous report as received from a physician refers to an 11 year old female patient without pertinent medical history or drug reactions/allergies. On 01-FEB-2013 the patient was vaccinated with first dose of GARDASIL (dose unknown, lot# reported as H014282, expired date: 09-APR-2014). Concomitant therapies included MENACTRA and DAPTACEL given at the same visit on 01-FEB-2013 at separate sites. In February, 2013 the patient developed a swollen, slightly warm, red rash at the injection site of the first dose of GARDASIL. The patient's mother called the office on 03-FEB-2013 to report the rash, but the exact time frame development of the rash was unspecified. The physician instructed the patient to take BENADRYL or CLARITIN and ibuprofen or TYLENOL. There was no lab diagnostics studies performed. At the time of reporting, the status of the patient was unknown. Additional information has been requested.
Severe joint ache; This is spontaneous report from a contactable consumer, the patient. A 53-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6200), via an unspecified route of administration in the left arm on 01Mar2021 at 09:30 (at the age of 53-year-old) as a single dose as a single dose for COVID-19 immunisation. The patient also received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613), via an unspecified route of administration in the left arm on 22Mar2021 (at the age of 53-year-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 01Mar2021 at 17:00, the patient experienced severe joint ache. The adverse event resulted in a visit to the doctors or other healthcare professional office/clinic visit. No therapeutic treatment was taken for the reported events. The clinical outcome of the event severe joint ache was not resolved.  No follow-up attempts are needed. No further information is expected.
Coughing, shortness of breath, runny nose, headache, body aches, fever
Immediate shoulder pain and swelling after vaccination. Continued with pain, swelling reduced rom for several weeks.  No f/c/s. No rash.
I noticed a long raised red bump on my left arm (3/21/2021) from the vaccine 1st dose received on 3/5/2021.  Feel okay other than the red bump.
Headache; Fever; Chills; Shakes; Body aches; Muscle aches; Fatigue; Shortness of breath; This is a spontaneous report from a contactable consumer, the patient. An 80-years-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ED7534) via an unknown route of administration in the left arm on 19Mar2021 at 17:15 (at the age of 80-years old) as single dose for COVID-19 immunisation. Medical history included chronic obstructive pulmonary disease (COPD), emphysema, angina, diabetes, hypertension and COVID-19 prior to vaccination. The patient had no allergies to medications, food, or other products. Concomitant medications included potassium (MANUFACTURER UNKNOWN) and amlodipine (MANUFACTURER UNKNOWN). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was diagnosed with COVID-19. Since vaccination, the patient had not been tested for COVID-19. On 20Mar2021 at 09:00, the patient experienced headache, fever, chills, shakes, body aches, muscle arches, fatigue and shortness of breath. Any therapeutic measures were not taken as a result of events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events body aches, chills, fatigue, fever, headache, muscle aches, shakes and shortness of breath was not recovered at the time of reporting.   No follow-up attempts are needed. No further information is expected.
Health service technician erroneously administered HEP A vs HEP B. Patient was informed of the error and educated on possible side effects. Patient experienced no side effects or complications.
w/in 15 " of vax pt exp burning sensation from arm up to head, h/a 2-3 days later sore throat, cough, vomiting, diarrhea, laryngitis, sinus congestion, spot in chest hurts;
No additional AE's; products experienced an excursion/have been administered to patients; This spontaneous report was received from a nurse referring to an 4-year-old patient of unknown gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On 16-SEP-2021, the patient was vaccinated with varicella virus vaccine live (Oka/Merck) (VARIVAX) 1 dose (Lot# U015682 has been verified to be a valid lot number for varicella virus vaccine live (Oka/Merck) (VARIVAX), expiration date reported as 18-MAY-2023) (strength, dose, route, frequency, were not provided) for prophylaxis.  The nurse reported that the vaccine experienced an excursion of 4 Celsius degrees (C) from -10 C to 8 C for 20 minutes on 07-SEP-2021 during the transport; and of 4C from -10 C to 8 C for 20 minutes on 09-SEP-2021, again during transport. Previous temperature excursion included from -10°C to 8°C (4C) for 7 hours and 30 minutes. And no adverse events were reported.  This is one of 26 reports received from the same source.; Sender's Comments:  US-009507513-2109USA005628:
Pt was experiencing shortness of breath, sweating, and racing heart, and dizziness. Code A was called and RN and MD came to attend. Vitals 1st set 90/41, pulse was 50, and O2 was 100%. Vitals 2nd set, 10 min later 100/60, pulse was 60, and O2 was 100%. Pt was given apple juice and given the okay to discharge home after waiting 10 more minute for observation.
Started my period five (5) days early - have a very regular cycle Swollen lymph nodes under left arm - arm vaccine was given in
This is a spontaneous case, initially received from pharmacist on 11-Dec-2017, concerning a patient of unspecified age and gender. The patient's medical history was not reported. On 09-Dec-2017 (09-Dec-2017 before 11-Dec-2017), the patient was administered with AFLURIA (TIV) (batch number: 14449211A, expiry date: 30-Jun-2018, dose, anatomical location and route of administration: not reported) after first excursion. It was reported that, the patient administered the product which was stored at 56.3 degrees F due to power outage of 7 hours. On an unspecified date, the patient was revaccinated and no adverse effects were noted. The reporter assessed the event as non-serious. Follow-up received from pharmacist on 12-Jan-2018: The report type was changed from invalid to spontaneous, as the pharmacist confirmed that only one patient received the flu-vaccine. It was reported that on an unspecified date, the patient was revaccinated and no adverse effects were noted. Narrative amended accordingly. Non-significant case correction received with IRD 12-Jan-2018: The event verbatim '2 patients administered after excursion 09DEC17 before 11DEC17' was replaced. Non-significant case correction received with IRD 12-Jan-2018: Narrative was corrected. 'The patient did not had any adverse effect' was changed to 'the patient did not experience any adverse effect'. 'On 09-Dec-2017 (09-Dec-2017 between 11-Dec-2017)' was changed to 'On 09-Dec-2017 (09-Dec-2017 before 11-Dec-2017)'.
Patient got Pfizer for their first COVID 19 vaccination and was mistakenly given Moderna for the second. The patient could not make it to facility at the time the pharmacist was there so a dose of Pfizer was set aside for her to come to the pharmacy later that afternoon. That day we also had second doses of Moderna being done at the facility. Patient came into pharmacy and told pharmacy staff she was here for her second dose and mistakenly told staff her first dose was Moderna and consent for was filled out and Moderna was given. Later that afternoon the pharmacist was notified that particular patient had already come and received Moderna when the Pfizer should have been given. Patient was notified.